Gad Soffer, Chief Operating Officer at Atara Biotherapeutics, Inc. (ATRA), sold 7,586 shares at $31.09 ($237K) on 2015-11-17, disclosed to the SEC on 2015-11-18.
Scheduled sale ($237k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.09 | 5,942 | $185K | 78.0% |
| 2 | $31.69 | 1,644 | $52K | 22.0% |
| Total | $31.22 avg | 7,586 | $237K | 100% |
| Filing → |
| ATRA | SELL | 2017-08-17 | $141K | — | Filing → |
| ATRA | SELL | 2017-05-17 | $192K | — | Filing → |
| ATRA | SELL | 2017-03-13 | $50K | — | Filing → |